Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 4,548 shares at $200.44 ($919K) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Scheduled sale ($919k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.44 | 1,840 | $369K | 40.1% |
| 2 | $201.26 | 481 | $97K | 10.5% |
| 3 | $202.32 | 1,017 | $206K | 22.4% |
| 4 | $203.61 | 432 | $88K | 9.6% |
| 5 | $204.80 | 290 | $59K | 6.5% |
| 6 | $205.78 | 297 |
| $61K |
| 6.6% |
| 7 | $206.84 | 146 | $30K | 3.3% |
| 8 | $207.46 | 45 | $9K | 1.0% |
| Total | $202.15 avg | 4,548 | $919K | 100% |
| Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |
| TWST | SELL | 2026-09-10 | $282K | — | Filing → |